Thymosin Beta 45mg
GHH Pharma Grade
Immune System Commander

Thymosin Beta 45mg

High-dose TB-4 for serious cardiac and systemic repair protocols

AED 2,549.00
Physician Required

Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide naturally secreted by the thymus gland — the organ that programmes T-cells, your immune system's elite soldiers. It has been used clinically in 35+ countries for viral infections, cancer immunotherapy, and immune deficiency states. It is one of the most clinically validated immune peptides in existence.

💉
Injectable / Oral
Administration
⏱️
2–4 weeks
First Results
🔄
6–12 week courses
Cycle Length
🎯

Clinical Uses

What conditions & goals this peptide addresses

Chronic viral infections (HBV, HCV, EBV, CMV)
Cancer immunotherapy support
Immune deficiency & frequent illness
COVID-19 / Long COVID immune recovery
Autoimmune conditions (immune modulation)
Chronic Lyme disease
Vaccine enhancement / adjuvant therapy

Key Benefits

The measurable outcomes you can expect

Dramatically increases T-cell count & function
Activates NK (natural killer) cells
Enhances dendritic cell maturation
Upregulates MHC class II expression
Reduces tumour immunosuppression
Antiviral & antifungal properties
Reduces chronic fatigue in immune-depleted patients
🔬

How It Works — Mechanism of Action

The precise biology behind this peptide's effects

Thymosin Alpha-1 stimulates T-cell differentiation and proliferation in the thymus. It upregulates cytokine production (IL-2, IFN-alpha, IFN-gamma), enhances natural killer cell activity, and promotes dendritic cell maturation — creating a comprehensive, coordinated immune enhancement without causing autoimmune flares.

Administration Guide

Subcutaneous injection. Reconstitute with bacteriostatic water. Best injected in the morning for alignment with natural immune rhythms.

💊

Dosage Protocol

GHH physician-guided dosing guidelines

Standard: 1.6 mg subcutaneous, 2× per week. Intensive (active infection): 1.6 mg daily for 7–14 days. Maintenance: 1.6 mg weekly. GHH protocol includes weekly immune panel monitoring.

🔄
Cycle Length
6–12 week courses, or ongoing for chronic conditions
🧊
Storage
Lyophilized: Refrigerate. Reconstituted: Refrigerate 2–8°C, use within 7 days.

When to Expect Results

A realistic timeline from first dose to full effect

Immune activation: within 24–48 hours of first dose. Significant clinical improvement in chronic viral illness: 4–12 weeks. Cancer support protocols: 3–6+ months.

Day 1–7
Week 2–4
Week 4–8
Week 8–16
⚠️

Side Effects

What to watch for and how common they are

Excellent safety profile across 30+ years of clinical use. Rare: mild injection site reaction, transient fatigue on initiation. No known serious adverse events.

🚫

Contraindications

Who should not use this peptide

Organ transplant recipients (immunostimulation may risk rejection). Active autoimmune conditions (use with caution — immune stimulating). Pregnancy.

Best Stacked With

Peptide synergies recommended by GHH physicians

BPC-157 for systemic healing support GHK-Cu for anti-inflammatory synergy Selank for neuro-immune modulation

Compare this peptide side-by-side

See how it stacks up against other protocols

🩺

Ready to Start Your Thymosin Protocol?

All peptide protocols require a physician consultation and blood work. Our licensed UAE physicians will craft a personalised plan for you.

The Science of Peptides

Understanding Your Body's Language

Peptides are not exotic foreign chemicals — they are the precise molecular signals your body has evolved to use for billions of years. Here's what you need to know.

🔭
"Peptides don't change who you are — they restore who you were designed to be."

— German Health Hub Clinical Philosophy

All peptides require UAE licensed physician review and mandatory blood work before dispensing. Information presented is for educational purposes only and does not constitute medical advice. Individual results may vary. Peptides are prescribed and dispensed under strict medical supervision by German Health Hub's licensed clinical team.